Kidneyintelx test leads to increased use of SGLT2 inhibitors
Title: Kidneyintelx Test Proven to Improve SGLT2 Inhibitor Therapy in Patients Publication Date: April 23, 2025 As announced by Renalytix plc, the application of their Kidneyintelx biomarker-based prognostic test has successfully driven a focused and significantly increased use of Sodium-Glucose…